Last reviewed · How we verify
Calcipotriol plus LEO 27989 ointment
Calcipotriol plus LEO 27989 ointment is a Small molecule drug developed by LEO Pharma. It is currently in Phase 1 development.
At a glance
| Generic name | Calcipotriol plus LEO 27989 ointment |
|---|---|
| Sponsor | LEO Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcipotriol plus LEO 27989 ointment CI brief — competitive landscape report
- Calcipotriol plus LEO 27989 ointment updates RSS · CI watch RSS
- LEO Pharma portfolio CI
Frequently asked questions about Calcipotriol plus LEO 27989 ointment
What is Calcipotriol plus LEO 27989 ointment?
Calcipotriol plus LEO 27989 ointment is a Small molecule drug developed by LEO Pharma.
Who makes Calcipotriol plus LEO 27989 ointment?
Calcipotriol plus LEO 27989 ointment is developed by LEO Pharma (see full LEO Pharma pipeline at /company/leo-pharma).
What development phase is Calcipotriol plus LEO 27989 ointment in?
Calcipotriol plus LEO 27989 ointment is in Phase 1.